Cargando…

Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies

Detalles Bibliográficos
Autores principales: Gopalakrishnan, Sathej, Menon, Rajeev, Suleiman, Ahmed A., Kater, Arnon P., Stilgenbauer, Stephan, Seymour, John F., Chyla, Brenda, Lu, Tong, Young Kim, Su, Roberts, Andrew W., Woyach, Jennifer A., Mensing, Sven, Salem, Ahmed Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659710/
https://www.ncbi.nlm.nih.gov/pubmed/38026788
http://dx.doi.org/10.1097/HS9.0000000000000983
_version_ 1785148369997398016
author Gopalakrishnan, Sathej
Menon, Rajeev
Suleiman, Ahmed A.
Kater, Arnon P.
Stilgenbauer, Stephan
Seymour, John F.
Chyla, Brenda
Lu, Tong
Young Kim, Su
Roberts, Andrew W.
Woyach, Jennifer A.
Mensing, Sven
Salem, Ahmed Hamed
author_facet Gopalakrishnan, Sathej
Menon, Rajeev
Suleiman, Ahmed A.
Kater, Arnon P.
Stilgenbauer, Stephan
Seymour, John F.
Chyla, Brenda
Lu, Tong
Young Kim, Su
Roberts, Andrew W.
Woyach, Jennifer A.
Mensing, Sven
Salem, Ahmed Hamed
author_sort Gopalakrishnan, Sathej
collection PubMed
description
format Online
Article
Text
id pubmed-10659710
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106597102023-11-17 Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies Gopalakrishnan, Sathej Menon, Rajeev Suleiman, Ahmed A. Kater, Arnon P. Stilgenbauer, Stephan Seymour, John F. Chyla, Brenda Lu, Tong Young Kim, Su Roberts, Andrew W. Woyach, Jennifer A. Mensing, Sven Salem, Ahmed Hamed Hemasphere Letter Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659710/ /pubmed/38026788 http://dx.doi.org/10.1097/HS9.0000000000000983 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter
Gopalakrishnan, Sathej
Menon, Rajeev
Suleiman, Ahmed A.
Kater, Arnon P.
Stilgenbauer, Stephan
Seymour, John F.
Chyla, Brenda
Lu, Tong
Young Kim, Su
Roberts, Andrew W.
Woyach, Jennifer A.
Mensing, Sven
Salem, Ahmed Hamed
Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title_full Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title_fullStr Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title_full_unstemmed Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title_short Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
title_sort relationship between venetoclax exposure and undetectable minimal residual disease rates in relapsed/refractory patients with chronic lymphocytic leukemia: a pooled analysis of six clinical studies
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659710/
https://www.ncbi.nlm.nih.gov/pubmed/38026788
http://dx.doi.org/10.1097/HS9.0000000000000983
work_keys_str_mv AT gopalakrishnansathej relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT menonrajeev relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT suleimanahmeda relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT katerarnonp relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT stilgenbauerstephan relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT seymourjohnf relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT chylabrenda relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT lutong relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT youngkimsu relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT robertsandreww relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT woyachjennifera relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT mensingsven relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies
AT salemahmedhamed relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies